Cannabinoids in health and disease / Natalya M. Kogan en Dialogues in Clinical Neuroscience, Año 2007 Vol.9 - No.4 (Diciembre)

Público ISBD [artículo]  inDialogues in Clinical Neuroscience > Año 2007 Vol.9 - No.4 (Diciembre) . - pp. 413–430 Título : Cannabinoids in health and disease Tipo de documento: texto impreso Autores: Natalya M. Kogan, Autor ; Raphael M. Mechoulam, Autor Fecha de publicación: 2022 Artículo en la página: pp. 413–430 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Cannabinoides, Terapéutica, Medicinal, Adicción Resumen: Cannabis sativa L. preparations have been used in medicine for millenia. However, concern over the dangers of abuse led to the banning of the medicinal use of marijuana in most countries in the 1930s. Only recently, marijuana and individual natural and synthetic cannabinoid receptor agonists and antagonists, as well as chemically related compounds, whose mechanism of action is still obscure, have come back to being considered of therapeutic value. Link: ./index.php?lvl=notice_display&id=28689 [artículo] Cannabinoids in health and disease [texto impreso] / Natalya M. Kogan, Autor ; Raphael M. Mechoulam, Autor . - 2022 . - pp. 413–430. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Dialogues in Clinical Neuroscience > Año 2007 Vol.9 - No.4 (Diciembre) . - pp. 413–430 Palabras clave: Cannabinoides, Terapéutica, Medicinal, Adicción Resumen: Cannabis sativa L. preparations have been used in medicine for millenia. However, concern over the dangers of abuse led to the banning of the medicinal use of marijuana in most countries in the 1930s. Only recently, marijuana and individual natural and synthetic cannabinoid receptor agonists and antagonists, as well as chemically related compounds, whose mechanism of action is still obscure, have come back to being considered of therapeutic value. Link: ./index.php?lvl=notice_display&id=28689

---

1 (1 - 1 / 1)